Articles

The economy can’t do much worse at creating jobs after a dismal 12,000 gain in hiring in October. Wall Street expects a big rebound in November.

While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s proposal that Medicare and Medicaid cover GLP-1 weight-loss drugs.

The U.S. expanded steadily in November, but hiring was subdued and inflation was still a nagging problem in some parts of the economy, a new Federal Reserve survey found.

Now could be a good time to invest in TIPS.

The pharma company now has two positive proof-of-concept trials under its belt, including its weight-loss pill.

With investors looking toward Friday’s November nonfarm-payrolls report, market participants see the potential that it could be overshadowed by an entirely different set of data: next Wednesday’s consumer-price index for the same month.

Michel Barnier is expected to be ousted in a no-confidence vote that could plunge markets into turmoil as Frances faces mounting pressure from the European Union to cut its budget deficit

Wall Street is excited about Marvell’s traction in custom offerings and partnership with Amazon’s AWS.

Among the Magnificent Seven, Alphabet is expected to have the highest free cash flow yield.

Service-oriented companies in the U.S. grew in November at the slowest pace in three months, reflecting uncertainty about how the incoming Trump administration will affect the economy.

Orders for manufactured goods posted the first increase after two straight monthly declines.

Thompson headed up the health benefits unit of UnitedHealth Group